SCIE期刊Nature Reviews Clinical Oncology 2024/2025影響因子:81.145 (NAT REV CLIN ONCOL) (1759-4774). (ONCOLOGY)(腫瘤學(xué))Science Ci

只看該作者 · 發(fā)表于 2025-3-23 21:53:02

Submitted on: 04 August 2017. Revised on: 11 August 2017. Accepted on: 17 August 2017. Nature Reviews Clinical Oncology

只看該作者 · 發(fā)表于 2025-3-24 00:47:26

Submitted on: 18 June 2018. Revised on: 06 July 2018. Accepted on: 14 July 2018. Nature Reviews Clinical Oncology

只看該作者 · 發(fā)表于 2025-3-24 05:29:20

只看該作者 · 發(fā)表于 2025-3-24 08:55:18

Submitted on: 07 October 2018. Revised on: 02 November 2018. Accepted on: 22 November 2018. Nature Reviews Clinical Oncology

只看該作者 · 發(fā)表于 2025-3-24 14:10:35

只看該作者 · 發(fā)表于 2025-3-24 18:26:08

Submitted on: 31 August 2007. Revised on: 05 October 2007. Accepted on: 27 October 2007. Nature Reviews Clinical Oncology

只看該作者 · 發(fā)表于 2025-3-24 21:50:21

Submitted on: 26 February 2011. Revised on: 19 March 2011. Accepted on: 25 March 2011. Nature Reviews Clinical Oncology

只看該作者 · 發(fā)表于 2025-3-25 00:48:41

Submitted on: 29 May 2013. Revised on: 28 June 2013. Accepted on: 23 July 2013. Nature Reviews Clinical Oncology

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 11:14
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved